Refine
Has Fulltext
- yes (14)
Is part of the Bibliography
- yes (14)
Year of publication
- 2021 (14) (remove)
Document Type
- Journal article (14)
Language
- English (14)
Keywords
- CD30 (1)
- CD319 (1)
- CRISPR/Cas9 (1)
- CS1 (1)
- EBER in situ hybridization (1)
- EZH1 (1)
- EZH2 (1)
- Epstein-Barr virus (1)
- GIST (1)
- GvHD (1)
- H3K27me3 (1)
- Hodgkin lymphoma (1)
- IRF4 (1)
- KIT (1)
- LESA (1)
- NFAT (1)
- Organoids (1)
- PLAG1 rearrangement (1)
- PTCL (1)
- RNA probe (1)
- T-cell non-Hodgkin's lymphomas (1)
- T-cell transfer (1)
- actin (1)
- acute graft-versus host disease (1)
- acute myeloid leukaemia (1)
- alloreactive T cells (1)
- aluminum granuloma (1)
- antigen loss (1)
- aortic adventitia (1)
- autoimmune disease (1)
- cancers and neoplasms (1)
- case report (1)
- cutaneous T-cell-lymphoma (1)
- ephitelial cells (1)
- epigenetics (1)
- epithelium (1)
- extramedullary disease (1)
- flow cytometry (1)
- gRNA-only (1)
- gastrointestinal infections (1)
- germline mutation (1)
- imaging (1)
- immunohistochemistry (1)
- kidney cancer (1)
- large cell transformation (1)
- lipoblastoma (1)
- lymph node stromal cells (1)
- lymph node transplantation (1)
- lymphoid hyperplasia (1)
- lymphoma (1)
- mTOR (1)
- machine learning (1)
- mastocytosis (1)
- mesenteric lymph node (1)
- metabolism (1)
- mitochondrial DNA (1)
- monoclonal antibody (1)
- mouse models (1)
- mtDNA (1)
- myasthenia (1)
- mycosis fungoides (1)
- naive T-cell gene editing (1)
- next generation sequencing (1)
- nodular lymphcyte (1)
- pan-RCC (1)
- panel sequencing (1)
- pathology (1)
- pediatric (1)
- plasma cells (1)
- pseudolymphoma (1)
- retroperitoneal tumor (1)
- seminoma (1)
- surgery (1)
- thymic epithelial tumor (1)
- thymitis (1)
- thymus (1)
- tumor spheroids (1)
- tumor-vessel wall-interface model (1)
- vascular wall stem and progenitor cells (1)
- vascularization model (1)
- vasculogenesis (1)
Institute
- Pathologisches Institut (14)
- Medizinische Klinik und Poliklinik II (5)
- Klinik und Poliklinik für Allgemein-, Viszeral-, Gefäß- und Kinderchirurgie (Chirurgische Klinik I) (3)
- Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie (3)
- Rudolf-Virchow-Zentrum (2)
- Abteilung für Funktionswerkstoffe der Medizin und der Zahnheilkunde (1)
- Center for Computational and Theoretical Biology (1)
- Comprehensive Cancer Center Mainfranken (1)
- Graduate School of Life Sciences (1)
- Institut für Anatomie und Zellbiologie (1)
T-cell lymphomas are highly heterogeneous and their prognosis is poor under the currently available therapies. Enhancers of zeste homologue 1 and 2 (EZH1/2) are histone H3 lysine-27 trimethyltransferases (H3K27me3). Despite the rapid development of new drugs inhibiting EZH2 and/or EZH1, the molecular interplay of these proteins and the impact on disease progression and prognosis of patients with T-cell lymphomas remains insufficiently understood. In this study, EZH1/2 mutation status was evaluated in 33 monomorphic epitheliotropic intestinal T-cell lymphomas by next generation sequencing and EZH1/2 and H3K27me3 protein expression levels were detected by immunohistochemistry in 46 T-cell lymphomas. Correlations with clinicopathologic features were analyzed and survival curves generated. No EZH1 mutations and one (3%) EZH2 missense mutation were identified. In univariable analysis, high EZH1 expression was associated with an improved overall survival (OS) and progression-free survival (PFS) whereas high EZH2 and H3K27me3 expression were associated with poorer OS and PFS. Multivariable analysis revealed EZH1 (hazard ratio (HR) = 0.183; 95% confidence interval (CI): 0.044–0.767; p = 0.020;) and EZH2 (HR = 8.245; 95% CI: 1.898–35.826; p = 0.005) to be independent, divergent prognostic markers for OS. In conclusion, EZH1/2 protein expression had opposing effects on the prognosis of T-cell lymphoma patients.